Article
Biochemistry & Molecular Biology
Haoran Li, Dingan Luo, Lakshmi Huttad, Mao Zhang, Youpeng Wang, Juan Feng, Yunfeng Ding, Bing Han
Summary: The study revealed the association between RIPK4 and the prognosis of HCC patients, showing that its overexpression inhibits invasion and metastasis in HCC through mechanisms involving the EMT and STAT3 pathways. Targeted inhibition of RIPK4 and the STAT3 pathway may offer potential therapeutic strategies to prevent postoperative recurrence and metastasis in HCC.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Min Li, Jun Wei, Guofeng Zhu, Shufang Fu, Xiaoyan He, Xinqian Hu, Yajie Yu, Yan Mou, Jia Wang, Xiaoling You, Xin Xiao, Tanrong Gu, Zhi Ye, Yunhong Zha
Summary: Blocking the receptor-interacting serine/threonine protein kinase 1 (RIPK1) is an effective treatment for systemic inflammatory response syndrome (SIRS), as it can inhibit necroptosis and prevent multiple organ failure. This study identified quizartinib, an FDA-approved drug, as a potent inhibitor of RIPK1, providing preclinical data for its potential use in treating RIPK1-dependent necroptosis-induced inflammatory diseases.
Article
Pharmacology & Pharmacy
Ge Jin, Lintao Wang, Jun Ma
Summary: Cardiac hypertrophy is a compensatory response to chronic pressure overload, and excessive angiotensin II plays a significant role in inducing cardiac hypertrophy. Previous studies have shown that STAT5, a member of the STATs family, is closely linked to non-tumor diseases, but its specific role in hypertrophy progression remains unclear. In this study, STAT5-IN-1, a STAT5 inhibitor, was administered to mice and H9c2s cells were used as cell models to investigate the effects of STAT5-IN-1 on cardiac hypertrophy induced by angiotensin II. The findings demonstrated that STAT5 inhibitor substantially decreased cardiac hypertrophy by reducing inflammation.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Multidisciplinary Sciences
Ewa Kilanczyk, Jesus M. Banales, Ewelina Jurewicz, Piotr Milkiewicz, Malgorzata Milkiewicz
Summary: The study revealed an interaction between PDC-E2 and phosphorylated STAT3 under cholestatic conditions, which may play a role in the development of primary biliary cholangitis.
SCIENTIFIC REPORTS
(2021)
Article
Infectious Diseases
Zhao-Ming Chen, Xiao-Yun Yang, Zheng-Tu Li, Wei-Jie Guan, Ye Qiu, Shao-Qiang Li, Yang-Qing Zhan, Zi-Ying Lei, Jing Liu, Jian-Quan Zhang, Zhong-Fang Wang, Feng Ye
Summary: The presence of anti-IFN-gamma autoantibodies inhibits immune responses of CD4(+) Th1 and CD8(+) T cells, and increases the release of IL-10.
INFECTION AND DRUG RESISTANCE
(2022)
Article
Medicine, Research & Experimental
Jiameng Lu, Xiaoqing Ji, Lixia Wang, Fei Sun, Chuanjun Huang, Haiying Peng, Yunxiu Jiang, Zihan Guo, Xinyi Liu, Yanbo Ji, Degan Lu
Summary: This study found that prophylactic administration of IL-27 can improve asthma by restoring the STAT1 and STAT3 pathways, alleviating the Th2 inflammatory environment in the lungs.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
(2022)
Article
Obstetrics & Gynecology
Sachiko Matsuzaki, Jean-Luc Pouly, Michel Canis
Summary: Persistent activation of signal transducer and activator of transcription 3 (STAT3) via interleukin-6 (IL-6) trans-signaling is involved in fibrosis of endometriosis.
HUMAN REPRODUCTION
(2022)
Article
Chemistry, Medicinal
Peng He, Ying Miao, Yue Sun, Aiwu Bian, Wangrui Jin, Jiangnan Ye, Huang Chen, Jia He, Yangrui Peng, Haijun Gu, Mingyao Liu, Zhengfang Yi, Yihua Chen
Summary: This study describes the design, synthesis, and structure-activity relationship studies of triaromatic heterocyclic derivatives as potent dual phosphorylation STAT3 inhibitors. The best compound 3h (HP590) was discovered with high inhibitory activity against p-Tyr(705) and p-Ser(727), resulting in the growth inhibition of gastric cancer both in vitro and in vivo.
JOURNAL OF MEDICINAL CHEMISTRY
(2022)
Review
Pharmacology & Pharmacy
Yuhan Su, Tianyu Tao, Xiuxing Liu, Wenru Su
Summary: This review summarizes the diverse roles of the JAK-STAT signaling pathway in ocular homeostasis and non-infectious uveitis (NIU) pathology, and discusses the safety and efficacy of JAK inhibitors for treating NIU and potential approaches for treatment optimization.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Cell Biology
Xiaoxuan Zhai, Wenjun Wang, Shukun Sun, Yu Han, Jiaxin Li, Shengchuan Cao, Ruochuan Li, Tonghui Xu, Qiuhuan Yuan, Jiali Wang, Shujian Wei, Yuguo Chen
Summary: This study demonstrated that 4-HNE contributes to cardiomyocyte necroptosis by regulating RIP1 protein degradation, while ALDH2-Tg mice showed significantly reduced necroptosis. Perfusion of 4-HNE enhanced cardiomyocyte necroptosis in a time- and concentration-dependent manner, and knockdown of RIP1 prevented 4-HNE-induced necroptosis.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Oncology
Ranzhiqiang Yang, Yinghui Song, Kashif Shakoor, Weimin Yi, Chuang Peng, Sulai Liu
Summary: Intrahepatic cholangiocarcinoma (ICC) is a primary malignant liver tumor with a poor prognosis, characterized by neoplastic transformation of intrahepatic biliary epithelial cells. Signal transducer and activator of transcription 3 (STAT3) is an important oncogene that may serve as a target for ICC treatment. Further research is needed to improve understanding of STAT3 and its role in ICC development.
MOLECULAR MEDICINE REPORTS
(2022)
Article
Multidisciplinary Sciences
Vadim M. Gumerov, Ekaterina P. Andrianova, Miguel A. Matilla, Karen M. Page, Elizabet Monteagudo-Cascales, Annette C. Dolphin, Tino Krell, Igor B. Zhulin
Summary: This study identifies a common amino acid recognition mechanism in bacteria, archaea, and humans, which may lead to improvements in drug targeting pain and neurobiological disorders.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Cardiac & Cardiovascular Systems
Marwa M. M. Refaie, Rehab Ahmed Rifaai, Michael Atef Fawzy, Sayed Shehata
Summary: This study investigated the role of dapagliflozin (DAP) in a Cd-induced cardiotoxicity model and found that DAP has protective properties against Cd-induced cardiotoxicity, possibly through its antioxidant, anti-inflammatory, anti-apoptotic properties and modulation of IL6/STAT3 and TLR2/TNF alpha-signaling pathways.
CARDIOVASCULAR TOXICOLOGY
(2022)
Review
Immunology
Xiaoxue Ma, Shingo Nakayamada
Summary: T follicular helper (Tfh) cells participate in humoral immune responses by promoting inflammation and aiding B cells survival, proliferation, maturation, and generation of autoantibodies. The plasticity of Tfh cells allows for adjustment of differentiation direction based on immune response level, regulated by various signaling factors such as cytokines, receptors, transcription factors, and genes. The STAT family signaling pathways play a crucial role in Tfh formation, with each member contributing to Tfh differentiation through mutual restraint and cooperation among cytokine-STAT signals.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Immunology
Sunghark Kwon
Summary: JAKs are important enzymes in the JAK-STAT signaling pathway, and dysfunctional JAKs can lead to severe immune system-related diseases. Various JAK inhibitors have been developed to block abnormal JAK-STAT signaling, but drug selectivity and resistance to these inhibitors remain challenges. This review discusses the role and structure of JAKs, as well as strategies for disrupting JAK dimerization to develop novel inhibitors.
FRONTIERS IN IMMUNOLOGY
(2022)